NCT06997003View on ClinicalTrials.gov

Evaluation of a New Laser Refractive Vision Correction Using the TENEO™ 317 Model 2

NARecruitingINTERVENTIONAL
Enrollment

81

Participants

Timeline

Start Date

June 16, 2025

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2026

Conditions
Hyperopia and Myopia
Interventions
DEVICE

Anterior treatment mode

Laser-in-situ-Keratomileusis (LASIK) surgery using OCTAVIUS treatment

DEVICE

Anterior treatment mode

Laser-in-situ-Keratomileusis (LASIK) surgery using OCTAVIUS treatment

DEVICE

Total treatment mode

Laser-in-situ-Keratomileusis (LASIK) surgery using OCTAVIUS treatment

Trial Locations (1)

76001

RECRUITING

Site 01, Zlín

Sponsors

Lead Sponsor

Bausch & Lomb GmbH
All Listed Sponsors
lead

Bausch & Lomb GmbH

INDUSTRY

NCT06997003 - Evaluation of a New Laser Refractive Vision Correction Using the TENEO™ 317 Model 2 | Biotech Hunter | Biotech Hunter